AngioDynamics (ANGO) Updates U.S. Tip Location Strategy
3/7/2014 8:53:27 AM
ALBANY, N.Y., March 6, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration (FDA) rejected its distribution partner, Medcomp Inc.'s, 510(k) application for the Celerity tip location system.
Help employers find you! Check out all the jobs and post your resume.
comments powered by